Your browser doesn't support javascript.
loading
Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations.
Davis, Skylar E; Cook, Anna K; Hall, Justin A; Voskobiynyk, Yuliya; Carullo, Nancy V; Boyle, Nicholas R; Hakim, Ahmad R; Anderson, Kristian M; Hobdy, Kierra P; Pugh, Derian A; Murchison, Charles F; McMeekin, Laura J; Simmons, Micah; Margolies, Katherine A; Cowell, Rita M; Nana, Alissa L; Spina, Salvatore; Grinberg, Lea T; Miller, Bruce L; Seeley, William W; Arrant, Andrew E.
Afiliación
  • Davis SE; Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Cook AK; Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Hall JA; Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Voskobiynyk Y; Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Carullo NV; Department of Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Boyle NR; Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Hakim AR; Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Anderson KM; Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Hobdy KP; Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Pugh DA; Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Murchison CF; Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, USA.
  • McMeekin LJ; Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Simmons M; Department of Neuroscience, Southern Research, Birmingham, AL, USA.
  • Margolies KA; Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Cowell RM; Department of Neuroscience, Southern Research, Birmingham, AL, USA.
  • Nana AL; Department of Neuroscience, Southern Research, Birmingham, AL, USA.
  • Spina S; Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Grinberg LT; Department of Neuroscience, Southern Research, Birmingham, AL, USA.
  • Miller BL; Department of Neurology, Memory and Aging Center, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
  • Seeley WW; Department of Neurology, Memory and Aging Center, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
  • Arrant AE; Department of Neurology, Memory and Aging Center, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Acta Neuropathol Commun ; 11(1): 70, 2023 04 28.
Article en En | MEDLINE | ID: mdl-37118844
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Pick / Degeneración Lobar Frontotemporal / Demencia Frontotemporal Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Acta Neuropathol Commun Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Pick / Degeneración Lobar Frontotemporal / Demencia Frontotemporal Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Acta Neuropathol Commun Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos